Join 400+ leaders, experts and researchers at Immuno 2024, connecting pharmaceutical & biotech representatives as well as academia for high-level discussions on the latest innovations in immune-oncology discovery & therapeutics development. Immuno 2024 features our ever popular 9th Annual Advances in Immuno-Oncology Congress and the 2nd Annual Targets & Cell Types Congress is attended by over 400 senior level attendees in London to network, debate and discuss the industry’s pressing challenges & opportunities; fostering partnerships & collaborations in the field. Do not miss out on attending these events to stay at the forefront of the latest advancements pushing the immune-oncology industry forward – from the discovery & development of cell & gene, antibody & combination therapies, through to the utilisation of omics techniques and technologies in IO as well as novel target identification & validation strategies. New to the agenda is the introduction of the Innovation & Collaboration track showcasing emerging biotechs & pioneering academic s pin off entering the market.

Event Link here.